CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2022. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,381 | -22.3% | 1,587 | 0.0% | 0.00% | – |
| Q2 2023 | $1,777 | +7.7% | 1,587 | 0.0% | 0.00% | – |
| Q1 2023 | $1,650 | -45.0% | 1,587 | -40.1% | 0.00% | – |
| Q3 2022 | $3,000 | -90.9% | 2,648 | -88.3% | 0.00% | – |
| Q2 2022 | $33,000 | -40.0% | 22,648 | -5.0% | 0.00% | – |
| Q1 2022 | $55,000 | -87.7% | 23,848 | -85.4% | 0.00% | – |
| Q4 2021 | $448,000 | +165.1% | 162,852 | +477.4% | 0.00% | – |
| Q3 2021 | $169,000 | +1308.3% | 28,202 | +525.3% | 0.00% | – |
| Q4 2020 | $12,000 | -98.9% | 4,510 | -99.2% | 0.00% | -100.0% |
| Q2 2020 | $1,068,000 | +31.7% | 567,903 | +19.1% | 0.01% | -28.6% |
| Q1 2020 | $811,000 | +83.9% | 476,782 | +213.4% | 0.01% | +133.3% |
| Q4 2019 | $441,000 | +1160.0% | 152,135 | +319.0% | 0.00% | – |
| Q2 2019 | $35,000 | -30.0% | 36,312 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $50,000 | +316.7% | 36,312 | +218.3% | 0.00% | – |
| Q4 2018 | $12,000 | -87.2% | 11,408 | -25.5% | 0.00% | -100.0% |
| Q3 2018 | $94,000 | -69.6% | 15,308 | -47.0% | 0.00% | -66.7% |
| Q2 2018 | $309,000 | +2276.9% | 28,899 | +2221.2% | 0.00% | – |
| Q1 2018 | $13,000 | – | 1,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |